IOL Chemicals receives approval for metformin in Europe

IOL Chemicals & Pharmaceuticals Ltd (IOLCP), one of India’s leading active pharmaceutical ingredient (API) manufacturers, has received CEP certification (Certificates of Suitability) for its product metformin hydrochloride from European Directorate for the Quality of Medicines & Healthcare (EDQM) authorities, Council of Europe, France.
 
Metformin hydrochloride is an API used in pharmaceutical products for treating people with type 2 diabetes.
 
The certificate, which is valid for a period of five years from the date of issue (ie April 17, 2015), will enable IOLCP to sell metformin hydrochloride in Europe resulting into increase in higher value added export turnover and margin.
 
“The company has already holding valid CEP certification (Certificates of Suitability) for its products ibuprofen & lamotrigine from European Directorate for the Quality of Medicines & Healthcare (EDQM) authorities, Council of Europe, France and selling these products in Europe,” said IOLCP in a press release.
 
IOL Chemicals, a major player in the organic chemicals space, has wide presence across various therapeutic categories like, pain management, anti-diabetic, anti-hypertensive, anti-convulsants, etc.